Modeling the Potential Impact of the 2014 American Academy of Pediatrics Respiratory Syncytial Virus Prophylaxis Guidance on Preterm Infant RSV Outcomes
Crossref DOI link: https://doi.org/10.1007/s40121-015-0097-3
Published Online: 2015-10-26
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McLaurin, Kimmie K.
Chatterjee, Archana
Makari, Doris
Funding for this research was provided by:
AstraZeneca